7. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518–522. 8. Joutel A, Monet M, Domenga V, Riant F, Tournier-Lasserve E (2004) Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling Pathway. Am J Hum Genet 74: 338–347. 9. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, et al. (2000) A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 5: 197–206. 10. Peters N, Opherk C, Zacherle S, Capell A, Gempel P, et al. (2004) CADASIL- associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. Exp Cell Res 299: 454–464. 11. Shawber C, Nofziger D, Hsieh JJ, Lindsell C, Bogler O, et al. (1996) Notch signaling inhibits muscle cell differentiation through a CBF1-independent pathway. Development 122: 3765–3773. 12. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, et al. (1997) Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350: 1511–1515. 13. Dichgans M, Ludwig H, Muller-Hocker J, Messerschmidt A, Gasser T (2000) Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet 8: 280–285. 14. Joutel A, Chabriat H, Vahedi K, Domenga V, Vayssiere C, et al. (2000) Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL. Neurology 54: 1874–1875. 15. Oberstein SA, Ferrari MD, Bakker E, van Gestel J, Kneppers AL, et al. (1999) Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research Group. Neurology 52: 1913–1915. 16. Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, et al. (2002) Diagnostic strategies in CADASIL. Neurology 59: 1134–1138. 17. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG (1993) Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke 24: 122–125. 18. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, et al. (1995) Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl) 89: 500–512. 19. Ishiko A, Shimizu A, Nagata E, Takahashi K, Tabira T, et al. (2006) Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol (Berl) 112: 333–339. 20. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, et al. (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 105: 597–605. 21. Iso T, Hamamori Y, Kedes L (2003) Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 23: 543–553. 22. Xue Y GX, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T (1999) Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 1999: 723– 730. 23. Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, et al. (2004) Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci U S A 101: 15949–15954. 24. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, et al. (2000) Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14: 1343– 1352. 25. Limbourg FP, Takeshita K, Radtke F, Bronson RT, Chin MT, et al. (2005) Essential role of endothelial Notch1 in angiogenesis. Circulation 111: 1826– 1832. 26. McCright B, Gao X, Shen L, Lozier J, Lan Y, et al. (2001) Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 128: 491–502. 27. Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, et al. (2004) Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 18: 2730–2735. 28. High FA, Zhang M, Proweller A, Tu L, Parmacek MS, et al. (2007) An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest 117: 353–363. 29. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, et al. (2006) Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444: 1083–1087. 30. Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, et al. (2007) Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445: 776–780. 31. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, et al. (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444: 1032–1037. 32. Lindner V, Booth C, Prudovsky I, Small D, Maciag T, et al. (2001) Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am J Pathol 159: 875–883. Cellular Effect of CADASIL Mutants of NOTCH3 33. Sweeney C, Morrow D, Birney YA, Coyle S, Hennessy C, et al. (2004) Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway. Faseb J 18: 1421–1423. 34. Liu H, Kennard S, Lilly B (2009) NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Circ Res 104: 466–475. 35. Tang Y, Urs S, Boucher J, Bernaiche T, Venkatesh D, et al. (2010) Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem 285: 17556– 17563. 36. Opherk C, Duering M, Peters N, Karpinska A, Rosner S, et al. (2009) CADASIL mutations enhance spontaneous multimerization of NOTCH3. Hum Mol Genet 18: 2761–2767. 37. Duering M, Karpinska A, Rosner S, Hopfner F, Zechmeister M, et al. (2011) Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. Hum Mol Genet. 38. Takahashi K, Adachi K, Yoshizaki K, Kunimoto S, Kalaria RN, et al. (2010) Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Hum Mol Genet 19: 79–89. 39. Zhang Y, Jia L, Lee SJ, Wang MM (2007) Conserved signal peptide of Notch3 inhibits interaction with proteasome. Biochem Biophys Res Commun 355: 245– 251. 40. Jia L, Yu G, Zhang Y, Wang MM (2009) Lysosome-dependent degradation of Notch3. Int J Biochem Cell Biol 41: 2594–2598. 41. Small D, Kovalenko D, Soldi R, Mandinova A, Kolev V, et al. (2003) Notch activation suppresses fibroblast growth factor-dependent cellular transformation. J Biol Chem 278: 16405–16413. 42. Meng H, Zhang X, Hankenson KD, Wang MM (2009) Thrombospondin 2 potentiates notch3/jagged1 signaling. J Biol Chem 284: 7866–7874. 43. Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, et al. (2003) Copper- binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet 12: 2753–2764. 44. Lindsell CE, Shawber CJ, Boulter J, Weinmaster G (1995) Jagged: a mammalian ligand that activates Notch1. Cell 80: 909–917. 45. Hicks C, Johnston SH, diSibio G, Collazo A, Vogt TF, et al. (2000) Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Nat Cell Biol 2: 515–520. 46. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, et al. (1995) Signalling downstream of activated mammalian Notch. Nature 377: 355–358. 47. Li L, Miano JM, Mercer B, Olson EN (1996) Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 132: 849–859. 48. Doi H, Iso T, Sato H, Yamazaki M, Matsui H, et al. (2006) Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-Jkappa- dependent pathway. J Biol Chem 281: 28555–28564. 49. Meng H, Zhang X, Lee SJ, Strickland DK, Lawrence DA, et al. (2010) Low density lipoprotein receptor-related protein-1 (LRP1) regulates thrombospondin- 2 (TSP2) enhancement of Notch3 signaling. J Biol Chem 285: 23047–23055. 50. Vooijs M, Schroeter EH, Pan Y, Blandford M, Kopan R (2004) Ectodomain shedding and intramembrane cleavage of mammalian Notch proteins is not regulated through oligomerization. J Biol Chem 279: 50864–50873. 51. Sakamoto K, Chao WS, Katsube K, Yamaguchi A (2005) Distinct roles of EGF repeats for the Notch signaling system. Exp Cell Res 302: 281–291. 52. Rand MD, Grimm LM, Artavanis-Tsakonas S, Patriub V, Blacklow SC, et al. (2000) Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol 20: 1825–1835. 53. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, et al. (2001) Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 108: 161–164. 54. Reaume AG, Conlon RA, Zirngibl R, Yamaguchi TP, Rossant J (1992) Expression analysis of a Notch homologue in the mouse embryo. Dev Biol 154: 377–387. 55. Del Amo FF, Smith DE, Swiatek PJ, Gendron-Maguire M, Greenspan RJ, et al. (1992) Expression pattern of Motch, a mouse homolog of Drosophila Notch, suggests an important role in early postimplantation mouse development. Development 115: 737–744. 56. Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, et al. (1996) Notch4/int- 3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122: 2251–2259. 57. Karlstrom H, Beatus P, Dannaeus K, Chapman G, Lendahl U, et al. (2002) A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc Natl Acad Sci U S A 99: 17119–17124. 58. Joutel A, Monet-Lepretre M, Gosele C, Baron-Menguy C, Hammes A, et al. (2010) Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 120: 433–45. 59. Takahashi K, Adachi K, Yoshizaki K, Kunimoto S, Kalaria RN, et al. (2010) Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Hum Mol Genet 19: 79–89. PLOS ONE | www.plosone.org 12 September 2012 | Volume 7 | Issue 9 | e44964